These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, Lantz M, Lester BM, Milio L. Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939 [Abstract] [Full Text] [Related]
6. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature]. Laqueille X, Launay C, Dervaux A, Kanit M. Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407 [Abstract] [Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study. Escher M, Daali Y, Chabert J, Hopfgartner G, Dayer P, Desmeules J. Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544 [Abstract] [Full Text] [Related]
8. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients. Vigezzi P, Guglielmino L, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L, Cozzolino E. J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005 [Abstract] [Full Text] [Related]
9. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Binder T, Vavrinková B. Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247 [Abstract] [Full Text] [Related]
11. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. Maremmani I, Pani PP, Pacini M, Perugi G. J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494 [Abstract] [Full Text] [Related]
12. Effects of a single 50% extra dose of methadone on heroin craving and mood in lower- versus higher-dose methadone patients. Strasser J, Wiesbeck GA, Meier N, Stohler R, Dürsteler-Macfarland KM. J Clin Psychopharmacol; 2010 Aug; 30(4):450-4. PubMed ID: 20571436 [Abstract] [Full Text] [Related]
13. [Buprenorphine or methadone for detoxification of young opioid addicts?]. Ebner R, Schreiber W, Zierer C. Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521 [Abstract] [Full Text] [Related]
14. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users. Abanades S, Farré M, Barral D, Torrens M, Closas N, Langohr K, Pastor A, de la Torre R. J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131 [Abstract] [Full Text] [Related]
16. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Pain Pract; 2008 Jul; 8(4):287-313. PubMed ID: 18503626 [Abstract] [Full Text] [Related]